Bone loss predicts subsequent cognitive decline in older women: The study of osteoporotic fractures

Journal of the American Geriatrics Society

Volumn 51, Issue 1, 2003, Pages 38-43

  Lui, Li Yung ^a,b   Stone, Katie ^a   Cauley, Jane A ^c   Hillier, Teresa ^d   Yaffe, Krstine ^a,b,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d KAISER PERMANENTE   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Bone loss; Cognitive decline; Older women

Indexed keywords

APOLIPOPROTEIN E; ESTROGEN;

AGE; AGED; ARTICLE; BODY MASS; BONE DENSITY; BONE MASS; COGNITIVE DEFECT; DISEASE ASSOCIATION; EDUCATION; FEMALE; FRAGILITY FRACTURE; GENOTYPE; HIGH RISK PATIENT; HIP FRACTURE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; POSTMENOPAUSE OSTEOPOROSIS; PREDICTION; RISK FACTOR; SMOKING HABIT;

AGED; AGED, 80 AND OVER; APOLIPOPROTEINS E; BONE DENSITY; COGNITION DISORDERS; DENSITOMETRY, X-RAY; FEMALE; GENOTYPE; HIP; HUMANS; MENTAL STATUS SCHEDULE; MULTIVARIATE ANALYSIS; OSTEOPOROSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0037245046     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1601-5215.2002.51007.x     Document Type: Article

References (28)

1. Evans DA. Estimated prevalence of Alzheimer's disease in the United States. Milbank Q 1990;68:267-289.
2. Yaffe K, Browner W, Cauley J et al. Association between bone mineral density and cognitive decline in older women. J Am Geriatr Soc 1999;47:1176-1182.
3. Zhang Y, Seshadri S, Ellison RC et al. Bone mineral density and verbal memory impairment: Third National Health and Nutrition Examination Survey. Am J Epidemiol 2001;154:795-802.
4. Browner WS, Pressman AR, Nevitt MC et al. Association between low bone density and stroke in elderly women. The study of osteoporotic fractures. Stroke 1993;24:940-946.
5. Jorgensen L, Engstad T, Jacobsen BK. Bone mineral density in acute stroke patients: Low bone mineral density may predict first stroke in women. Stroke 2001;32:47-51.
6. Shiraki M, Shiraki Y, Aoki C et al. Association of bone mineral density with apolipoprotein E phenotype. J Bone Miner Res 1997;12:1438-1445.
7. Salamone LM, Cauley JA, Zmuda J et al. Apolipoprotein E gene polymorphism and bone loss: Estrogen status modifies the influence of apolipoprorein E on bone loss. J Bone Miner Res 2000;15:308-314.
8. Cauley JA, Zmuda JM, Yaffe K et al. Apolipoprotein E polymorphism. A new genetic marker of hip fracture risk - The Study of Osteoporotic Fractures. J Bone Miner Res 1999;14:1175-1181.
9. Johnston JM, Cauley JA, Ganguli M. APOE 4 and hip fracture risk in a community-based study of older adults. J Am Geriatr Soc 1999;47:1342-1345.
10. Jonker C, Schmand B, Lindeboom J et al. Association between apolipoprorein E epsilon4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia. Arch Neurol 1998;55:1065-1069.
11. Yaffe K, Cauley J, Sands L et al. Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women. Arch Neurol 1997;54:1110-1114.
12. Cummings SR, Nevitt MC, Browner WS et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 1995;332:767-773.
13. Steiger P, Cummings SR, Black DM et al. Age-related decrements in bone mineral density in women over 65. J Bone Miner Res 1992;7:625-632.
14. Crum RM, Anthony JC, Bassett SS et al. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA 1993;269:2386-2391.
15. Bachman DL, Wolf PA, Linn RT et al. Incidence of dementia and probable Alzheimer's disease in a general population: The Framingham Study. Neurology 1993;43:515-519.
16. Kamboh MI, Ferrell RE, Kottke B. Genetic studies of human apolipoproteins. V. A novel rapid procedure to screen apolipoprotein E polymorphism. J Lipid Res 1988;29:1535-1543.
17. Sarkisian CA, Liu H, Gutierrez PR et al. Modifiable risk factors predict functional decline among older women: A prospectively validated clinical prediction tool. The Study of Osteoporotic Fractures Research Group. J Am Geriatr Soc 2000;48:170-178.
18. Yesavage JA. Geriatric Depression Scale. Psychopharmacol Bull 1988;24:709-711.
19. Hannan MT, Felson DT, Dawson-Hughes B et al. Risk factors for longitudinal bone loss in elderly men and women: The Framingham Osteoporosis Study. J Bone Miner Res 2000;15:710-720.
20. Wimalawansa SJ. Prevention and treatment of osteoporosis: Efficacy of combination of hormone replacement therapy with other antiresorptive agents. J Clin Densitom 2000;3:187-201.
21. Matthews K, Cauley J, Yaffe K et al. Estrogen replacement therapy and cognitive decline in older community women [see comments]. J Am Geriatr Soc 1999;47:518-523.
22. Mulnard RA, Cotman CW, Kawas C et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: A randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA 2000;283:1007-1015.
23. Nguyen TV, Sambrook PN, Eisman JA. Bone loss, physical activity, and weight change in elderly women: The Dubbo Osteoporosis Epidemiology Study. J Bone Miner Res 1998;13:1458-1467.
24. Barrett-Connor E, Edelstein SL, Corey-Bloom J et al. Weight loss precedes dementia in community-dwelling older adults. J Am Geriatr Soc 1996;44:1147-1152.
25. White H, Pieper C, Schmader K. The association of weight change in Alzheimer's disease with severity of disease and mortality: A longitudinal analysis. J Am Geriatr Soc 1998;46:1223-1227.
26. Ershler WB. Interleukin-6: A cytokine for gerontologists. J Am Geriatr Soc 1993;41:176-181.
27. Papanicolaou DA, Wilder RL, Manolagas SC et al. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 1998;128:127-137.
28. Licastro F, Pedrini S, Caputo L et al. Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: Peripheral inflammation or signals from the brain? J Neuroimmunol 2000;103:97-102.